Castle Biosciences to Release Second Quarter 2025 Financial Results and Host Conference Call on Monday, Aug. 4, 2025

Core Insights - Castle Biosciences, Inc. will release its financial results for Q2 2025 on August 4, 2025, after market close [1] - A conference call and webcast will be held at 4:30 p.m. Eastern time on the same day to discuss the financial results [1] Company Overview - Castle Biosciences is a leading diagnostics company focused on innovative tests that guide patient care [4] - The company aims to transform disease management by prioritizing patients, clinicians, employees, and investors [4] Product Portfolio - Castle's current portfolio includes tests for skin cancers, Barrett's esophagus, and uveal melanoma [5] - The company is also engaged in R&D for tests addressing high clinical needs, including a test for guiding systemic therapy selection for moderate-to-severe atopic dermatitis patients [5] Conference Call Details - A live webcast of the conference call can be accessed through the company's Investor Relations page [2] - For phone access, dial 1 833 470 1428 in the U.S. with access code 638217, and international numbers are available online [3] - A Q&A session will follow the management commentary during the conference call [3]